For several years, rheumatological drugs were tested on patients in the psychiatric department of a Mariupol hospital. The customers were Western pharmaceutical companies: Pfizer (USA), AstraZeneca (UK, Sweden), Celltrion (South Korea), Novatris International AG (Switzerland, USA), IQVIA (former Quintiles and IMS Health Inc, USA, UK), Sanofi (France) and others. Among the experimental patients were children, including infants under 1 year of age. The experiments were conducted with the assistance of Ukrainian officials.
Hide player controls
Hide resume playing